1. Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT
    Lieven D. Declercq et al, 2016, Front. Pharmacol. CrossRef
  2. Protective effect of paeoniflorin on inflammation and apoptosis in the cerebral cortex of a transgenic mouse model of Alzheimer's disease
    XINYI GU et al, 2016 CrossRef
  3. Design, synthesis and bioevalucation of novel 2,3-dihydro-1 H -inden-1-amine derivatives as potent and selective human monoamine oxidase B inhibitors based on rasagiline
    Xuan Xiao et al, 2018, European Journal of Medicinal Chemistry CrossRef
  4. Newly Developed Drugs for Alzheimer’s Disease in Relation to Energy Metabolism, Cholinergic and Monoaminergic Neurotransmission
    Jan Korábečný et al, 2018, Neuroscience CrossRef
  5. DL -3- n -butylphthalide-Edaravone hybrids as novel dual inhibitors of amyloid- β aggregation and monoamine oxidases with high antioxidant potency for Alzheimer’s therapy
    Xiaoming Qiang et al, 2017, Bioorganic & Medicinal Chemistry Letters CrossRef
  6. Alterations in the nigrostriatal dopamine system after acute systemic PhIP exposure
    Zeynep Sena Agim et al, 2018, Toxicology Letters CrossRef
  7. Reactive Oxygen Species: Physiological and Physiopathological Effects on Synaptic Plasticity
    Thiago Fernando Beckhauser et al, 2016, J Exp Neurosci CrossRef
  8. Multifunctional 5,6-dimethoxybenzo[ d ]isothiazol-3(2 H )-one- N -alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β -amyloid aggregation inhibitory activities as potential agents against Alzheimer’s disease
    Rui Xu et al, 2018, Bioorganic & Medicinal Chemistry CrossRef
  9. An investigation of the monoamine oxidase inhibition properties of pyrrolo[3,4-f]indole-5,7-dione and indole-5,6-dicarbonitrile derivatives.
    Zhanna V Chirkova et al, 2018, Drug Dev Res CrossRef
  10. Passive Aβ Immunotherapy: Current Achievements and Future Perspectives
    Stephan Schilling et al, 2018, Molecules CrossRef
  11. Platelets: Peripheral Biomarkers of Dementia?
    Oluwatomi Akingbade et al, 2018, JAD CrossRef
  12. Exosomes: a novel therapeutic target for Alzheimer’s disease?
    Zhi-You Cai et al, 2018, Neural Regen Res CrossRef
  13. Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism
    Jana Hroudová et al, 2016, European Journal of Medicinal Chemistry CrossRef
  14. Monoamine oxidase-B inhibitor protects degenerating spinal neurons, enhances nerve regeneration and functional recovery in sciatic nerve crush injury model
    Al-Shimali M. Hussain et al, 2018, Neuropharmacology CrossRef
  15. Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease
    Martín Estrada Valencia et al, 2018, European Journal of Medicinal Chemistry CrossRef
  16. Membrane Reconstitution of Monoamine Oxidase Enzymes on Supported Lipid Bilayers
    Liulin Wang et al, 2018, Langmuir CrossRef
  17. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
    Qi Li et al, 2018, European Journal of Medicinal Chemistry CrossRef
  18. Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework
    Anton Shetnev et al, 2018, Bioorganic & Medicinal Chemistry Letters CrossRef
  19. Chromones: privileged scaffolds for the production of multi-target-directed-ligand agents for the treatment of Alzheimer’s disease
    Carlos F. M. Silva et al, 2018, Expert Opinion on Drug Discovery CrossRef
  20. Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
    Piyoosh Sharma et al, 2018, Progress in Neurobiology CrossRef
  21. Tryptophan-Tyrosine Dipeptide, the Core Sequence of β-Lactolin, Improves Memory by Modulating the Dopamine System
    Yasuhisa Ano et al, 2019, Nutrients CrossRef
  22. Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease
    Tao Wang et al, 2019, European Journal of Medicinal Chemistry CrossRef
  23. New flavonoid – N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties
    Martín Estrada-Valencia et al, 2019, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
  24. Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase
    Bhupinder Kumar et al, 2019, European Journal of Medicinal Chemistry CrossRef
  25. Alternative splicing in serotonergic system: Implications in neuropsychiatric disorders
    Eva Latorre et al, 2019, J Psychopharmacol CrossRef
  26. Identification of AV-1451 as a Weak, Nonselective Inhibitor of Monoamine Oxidase
    Lindsey R Drake et al, 2019, ACS Chem. Neurosci. CrossRef
  27. Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease
    Edilio Borroni et al, 2017, J Pharmacol Exp Ther CrossRef
  28. Benextramine and derivatives as novel human monoamine oxidases inhibitors: an integrated approach
    Maria Luisa Di Paolo et al, 2019, FEBS J CrossRef
  29. Artificial neural networks-based classification of emotions using wristband heart rate monitor data
    Yi-Chun Chen et al, 2019, Medicine CrossRef
  30. Danshensu attenuates scopolamine and amyloid-β-induced cognitive impairments through the activation of PKA-CREB signaling in mice
    Ho Jung Bae et al, 2019, Neurochemistry International CrossRef
  31. Highly sensitive isotope-dilution liquid-chromatography–electrospray ionization–tandem-mass spectrometry approach to study the drug-mediated modulation of dopamine and serotonin levels in Caenorhabditis elegans
    Fabian Schumacher et al, 2015, Talanta CrossRef
  32. Neuroprotective effects of the monoamine oxidase inhibitor tranylcypromine and its amide derivatives against Aβ(1–42)-induced toxicity
    Filippo Caraci et al, 2015, European Journal of Pharmacology CrossRef
  33. Synthesis, biological evaluation, and molecular modeling of nitrile-containing compounds: Exploring multiple activities as anti-Alzheimer agents.
    Daniel Silva et al, 2020, Drug Dev Res CrossRef
  34. Inhibition of monoamine oxidase by benzoxathiolone analogues
    Samantha Mostert et al, 2016, Bioorganic & Medicinal Chemistry Letters CrossRef
  35. Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system
    Douglas L. Feinstein et al, 2016, J. Neurochem. CrossRef
  36. Drugs related to monoamine oxidase activity
    Zdeněk Fišar, 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry CrossRef
  37. Rhizophora mucronata attenuates beta-amyloid induced cognitive dysfunction, oxidative stress and cholinergic deficit in Alzheimer’s disease animal model
    Natarajan Suganthy et al, 2016, Metab Brain Dis CrossRef
  38. 8-Aminomethyl-7-hydroxy-4-methylcoumarins as Multitarget Leads for Alzheimer's Disease
    José L. Domínguez et al, 2016, ChemistrySelect CrossRef
  39. Effects of different fatty acids composition of phosphatidylcholine on brain function of dementia mice induced by scopolamine
    Miao-miao Zhou et al, 2016, Lipids Health Dis CrossRef
  40. Alkaloid extracts from shea butter and breadfruit as potential inhibitors of monoamine oxidase, cholinesterases, and lipid peroxidation in rats’ brain homogenates: a comparative study
    Stephen A. Adefegha et al, 2016, Comp Clin Pathol CrossRef
  41. null
    J. Wallach et al, 2017 CrossRef
  42. null
    Ilaria Canobbio et al, 2017 CrossRef
  43. Critical Evaluation of Current Alzheimer′s Drug Discovery (2018-19) & Futuristic Alzheimer drug model approach
    Atukuri Dorababu, 2019, Bioorganic Chemistry CrossRef
  44. The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase
    Samantha Mostert et al, 2017, European Journal of Medicinal Chemistry CrossRef
  45. Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer’s disease: Design, synthesis and biological evaluation
    Chaoquan Tian et al, 2019, Bioorganic Chemistry CrossRef
  46. In silico discovery of noteworthy multi-targeted acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease
    Sabreena Chowdhury Raka et al, 2019, Orient Pharm Exp Med CrossRef
  47. Propargylamine-derived multi-target directed ligands for Alzheimer‘s disease therapy
    Maria do Carmo Carreiras et al, 2019, Bioorganic & Medicinal Chemistry Letters CrossRef
  48. A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease
    Soo Youn Lee et al, 2020, Front. Pharmacol. CrossRef
  49. Progress in Target Drug Molecules for Alzheimer's Disease
    Jiayang Xie et al, 2020, CTMC CrossRef
  50. Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ1-42 aggregation
    Erika Plazas Gonzalez et al, 2020, Bioorganic Chemistry CrossRef
  51. Egg yolk phospholipids reverse scopolamine–induced spatial memory deficits in mice by attenuating cholinergic damage
    Zhijie Bao et al, 2020, Journal of Functional Foods CrossRef
  52. N-Acetylcysteine and Safranal prevented the brain damage induced by hyperthyroidism in adult male rats
    Asmaa S. Shahat et al, 2020, Nutritional Neuroscience CrossRef
  53. Design, Synthesis and Evaluation of O ‐Pentyne Substituted Diphenylpyrimidines as Monoamine Oxidase and Acetylcholinesterase Inhibitors
    Vijay Kumar et al, 2020, ChemistrySelect CrossRef
  54. The TLC-Bioautography as a Tool for Rapid Enzyme Inhibitors detection - A Review
    Barbora Legerská et al, 2020, Critical Reviews in Analytical Chemistry CrossRef
  55. Optimization of the Synthesis of 18 F‐D 2 ‐Deprenyl With Mild 18 F ‐Fluorination and Minimum Precursor Input for PET Imaging of Neuroinflammation
    Sang Ju Lee et al, 2020, Bull. Korean Chem. Soc. CrossRef
  56. Identification of phytochemicals from North African plants for treating Alzheimer's diseases and of their molecular targets by in silico network pharmacology approach
    Karim Raafat, 2020, Journal of Traditional and Complementary Medicine CrossRef
  57. null
    Pablo Duarte et al, 2020 CrossRef
  58. Utility of Reactive Species Generation in Plasma Medicine for Neuronal Development
    Sarmistha Mitra et al, 2020, Biomedicines CrossRef
  59. Selective Interactions of O-Methylated Flavonoid Natural Products with Human Monoamine Oxidase-A and -B
    Narayan D. Chaurasiya et al, 2020, Molecules CrossRef
  60. Inhibition of BACE1, MAO‐B, cholinesterase enzymes, and anti‐amyloidogenic potential of selected natural phytoconstituents: Multi‐target‐directed ligand approach
    Suman Chowdhury et al, 2020, J Food Biochem CrossRef
  61. Acetylcholinesterase and butyrylcholinesterase inhibitory activities of khellactone coumarin derivatives isolated from Peucedanum japonicum Thurnberg
    Jeong Hyun Heo et al, 2020, Sci Rep CrossRef
  62. Effects of novel 17β-hydroxysteroid dehydrogenase type 10 inhibitors on mitochondrial respiration
    Zdeněk Fišar et al, 2020, Toxicology Letters CrossRef
  63. Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer’s Disease
    Marta Campora et al, 2021, Pharmaceuticals CrossRef
  64. Monoamine oxidases in age-associated diseases: New perspectives for old enzymes
    Yohan Santin et al, 2021, Ageing Research Reviews CrossRef
  65. Acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease – a patent review (2016–present)
    Martina Bortolami et al, 2021, Expert Opinion on Therapeutic Patents CrossRef
  66. Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer’s Disease
    Marta Campora et al, 2021, ACS Chem. Neurosci. CrossRef
  67. Occurrence of Morpholine in Central Nervous System Drug Discovery
    Elena Lenci et al, 2021, ACS Chem. Neurosci. CrossRef
  68. Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review
    Aswir Abd Rashed et al, 2021, Molecules CrossRef
  69. Multifunctional Ligands Targeting Phosphodiesterase as the Future Strategy for the Symptomatic and Disease-Modifying Treatment of Alzheimer’s Disease
    Agnieszka Jankowska et al, 2020, CMC CrossRef
  70. Whether short peptides are good candidates for future neuroprotective therapeutics?
    Renata Perlikowska, 2021, Peptides CrossRef
  71. Recent Updates in the Alzheimer’s Disease Etiopathology and Possible Treatment Approaches: A Narrative Review of Current Clinical Trials
    Elahe Zarini-Gakiye et al, 2020, CMP CrossRef
  72. Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine
    Dmitriy Matveychuk et al, 2021, Cell Mol Neurobiol CrossRef
  73. Antidepressant-like effects of a new dihydro isoquinoline and its chemical precursors in mice: involvement of serotonin and dopaminergic systems
    Javier Porras-Ramírez et al, 2020, Can. J. Chem. CrossRef
  74. Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer’s disease agents
    Chanyuan Ye et al, 2021, Bioorganic Chemistry CrossRef
  75. Antioxidant and Anti-Inflammatory Profiles of Spent Coffee Ground Extracts for the Treatment of Neurodegeneration
    Simone Angeloni et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  76. Metabolic depletion of synaptosomal enzymes linked with neurotoxicity and ovarian dysfunction by phenolic antioxidants of Croton zambsicus leaves in rats exposed to chronic mixture of anthropogenic toxicant
    J.K. Akintunde et al, 2021, Metabolism Open CrossRef
  77. null
    Sudhir Raghavan et al, 2021 CrossRef
  78. Role of Monoamine Oxidase Activity in Alzheimer’s Disease: An Insight into the Therapeutic Potential of Inhibitors
    Tapan Behl et al, 2021, Molecules CrossRef
  79. Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug
    Pricila Pflüger et al, 2021, European Journal of Pharmacology CrossRef
  80. Pyridazinones containing dithiocarbamoyl moieties as a new class of selective MAO-B inhibitors
    Pedro Besada et al, 2021, Bioorganic Chemistry CrossRef
  81. Deciphering the detailed structure–activity relationship of coumarins as Monoamine oxidase enzyme inhibitors—An updated review
    Vishal Payyalot Koyiparambath et al, 2021, Chem Biol Drug Des CrossRef
  82. Curcumin–Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders
    Elías Quezada et al, 2021, Molecules CrossRef
  83. Neuroprotective Efficacy of Apple Cider Vinegar on Zinc-High Fat Diet-Induced Mono Amine Oxidase Alteration in Murine Model of AD
    Smriti Tripathi et al, 2021, Journal of the American College of Nutrition CrossRef
  84. Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies
    Ahmed Elkamhawy et al, 2021, Bioorganic Chemistry CrossRef
  85. Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer’s Disease
    Huan Wang et al, 2019, ACS Chem. Neurosci. CrossRef
  86. Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer’s Disease
    Lucie Cahlíková et al, 2021, Molecules CrossRef
  87. The Positive Modulation Effect of a 6-Week Consumption of an Anthocyanin-Rich Mulberry Milk on Working Memory, Cholinergic, and Monoaminergic Functions in Healthy Working-Age Adults
    Wipawee Thukham-mee et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  88. The Reactive Species Interactome in the brain
    Elise Malard et al, 2021, Antioxidants & Redox Signaling CrossRef
  89. Insights into the Mechanism of the Therapeutic Potential of Herbal Monoamine Oxidase Inhibitors in Neurological Diseases
    Ashi Mannan et al, 2021, CDT CrossRef
  90. Exploring the Role of Monoamine Oxidase Activity in Aging and Alzheimer’s Disease
    Md. Sohanur Rahman et al, 2021, CPD CrossRef
  91. Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review
    Zahra Haghighijoo et al, 2021, European Journal of Medicinal Chemistry CrossRef
  92. Anti-Alzheimer potential of a waste by-product (peel) of Omani pomegranate fruits: Quantification of phenolic compounds, in-vitro antioxidant, anti-cholinesterase and in-silico studies
    Rehab Khokar et al, 2021, Biocatalysis and Agricultural Biotechnology CrossRef
  93. Pharmacological investigations on efficacy of Phlorizin a sodium-glucose co-transporter (SGLT) inhibitor in mouse model of intracerebroventricular streptozotocin induced dementia of AD type
    Reena Rani et al, 2021 CrossRef
  94. Potential Role of Heterocyclic Aromatic Amines in Neurodegeneration
    Tauqeerunnisa Syeda et al, 2022, Chem. Res. Toxicol. CrossRef
  95. Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer’s disease agents
    Sheunopa C. Mzezewa et al, 2021, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
  96. Fluoxetine ameliorates Alzheimer’s disease progression and prevents the exacerbation of cardiovascular dysfunction of socially isolated depressed rats through activation of Nrf2/HO-1 and hindering TLR4/NLRP3 inflammasome signaling pathway
    Karema Abu-Elfotuh et al, 2022, International Immunopharmacology CrossRef
  97. Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases
    David Allan Butterfield et al, 2022, Molecules CrossRef
  98. Amelioration of cognitive and biochemical impairment in Aβ-based rodent model of Alzheimer’s disease following fractionated X-irradiation
    Anna Khan et al, 2022, Radiat Environ Biophys CrossRef
  99. null
    Kaléu Mormino Otoni et al, 2022 CrossRef
  100. A Critical Review on Recent Trends on Pharmacological Applications of Pyrazolone Endowed Derivatives
    Ghulam Mustafa et al, 2022, Journal of Molecular Structure CrossRef
  101. Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study
    Danish Iqbal et al, 2022, Entropy CrossRef
  102. Effect of diet supplemented with African Star Apple Fruit Pulp on purinergic, cholinergic and monoaminergic enzymes, TNF-α expression and redox imbalance in the brain of hypertensive rats
    Tosin A. Olasehinde et al, 2022, Nutritional Neuroscience CrossRef
  103. Computational Prediction of Potential Drug-like Compounds from Cannabis sativa Leaf Extracts Targeted towards Alzheimer Therapy
    Adewale Oluwaseun Fadaka et al, 2022, Journal of Molecular Liquids CrossRef
  104. Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer’s disease
    François-Xavier Toublet et al, 2021, European Journal of Medicinal Chemistry CrossRef
  105. Design, synthesis and biological evaluation of light-driven on–off multitarget AChE and MAO-B inhibitors
    Marco Paolino et al, 2022, RSC Med. Chem. CrossRef
  106. Pharmacological Exploration of Triazole-based Therapeutics for Alzheimer’s Disease: An Overview
    Chandu Anantha Lakshmi Prasanna et al, 2022, CDT CrossRef
  107. Purification, identification and in silico models of alkaloids from Nardostachys jatamansi — bioactive compounds for neurodegenerative diseases
    Nagasathiya Krishnan et al, 2022, Biomass Conv. Bioref. CrossRef
  108. The regulatory role of AP-2β in monoaminergic neurotransmitter systems: insights on its signalling pathway, linked disorders and theragnostic potential
    Mohamed H. Al-Sabri et al, 2022, Cell Biosci CrossRef
  109. The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents
    Tim Keuler et al, 2022, ACS Pharmacol. Transl. Sci. CrossRef
  110. Amyloid Cascade Hypothesis for the Treatment of Alzheimer’s Disease: Progress and Challenges
    Tong Wu et al, 2022, Aging and disease CrossRef
  111. Anxiety, Insomnia, and Memory Impairment in Metabolic Syndrome Rats Are Alleviated by the Novel Functional Ingredients from Anacardium occidentale
    Pratthana Srichomphu et al, 2022, Antioxidants CrossRef
  112. Molecular docking and molecular dynamics approach to identify potential compounds in Huperzia squarrosa for treating Alzheimer’s disease
    Bui Thanh Tung et al, 2022 CrossRef
  113. Emerging Therapeutics Agents and Recent Advances in Drug Repurposing for Alzheimer’s Disease
    null Neha et al, 2022, Ageing Research Reviews CrossRef
  114. Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
    Siew Lee Cheong et al, 2022, Pharmaceuticals CrossRef
  115. Tacrine-Based Hybrids: Past, Present, and Future
    Anna Bubley et al, 2023, IJMS CrossRef
  116. Age-Related Alterations in the Level and Metabolism of Serotonin in the Brain of Males and Females of Annual Turquoise Killifish (Nothobranchius furzeri)
    Valentina S. Evsiukova et al, 2023, IJMS CrossRef
  117. (S)-N-Benzyl-1-phenyl-3,4-dihydroisoqunoline-2(1H)-carboxamide Derivatives, Multi-Target Inhibitors of Monoamine Oxidase and Cholinesterase: Design, Synthesis, and Biological Activity
    Qing-Hao Jin et al, 2023, Molecules CrossRef
  118. Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer’s disease
    Donia E. Hafez et al, 2023, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
  119. Current Drug Targets in Alzheimer’s Associated Memory Impairment: A Comprehensive Review
    Anna Mathew et al, 2023, CNSNDDT CrossRef
  120. In silico molecular docking and molecular dynamic simulation of agarwood compounds with molecular targets of Alzheimer’s disease 
    Phaniendra Alugoju et al, 2023, F1000Res CrossRef
  121. Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
    Laura Marinela Ailioaie et al, 2023, Pharmaceutics CrossRef
  122. An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects
    Pratibha Sharma et al, 2023, Life Sciences CrossRef
  123. Clinical Biomarkers and Novel Drug Targets to Cut Gordian Knots of Alzheimer's Disease
    Abdul Jalil Shah et al, 2023, CMP CrossRef
  124. Microorganism-Derived Molecules as Enzyme Inhibitors to Target Alzheimer’s Diseases Pathways
    Thi Hanh Nguyen et al, 2023, Pharmaceuticals CrossRef
  125. Synthesis and Biological Evaluation of O6-Aminoalkyl-Hispidol Analogs as Multifunctional Monoamine Oxidase-B Inhibitors towards Management of Neurodegenerative Diseases
    Ahmed H. E. Hassan et al, 2023, Antioxidants CrossRef
  126. Rational Design of Multifunctional Ferulic Acid Derivatives Aimed for Alzheimer’s and Parkinson’s Diseases
    Eduardo Gabriel Guzmán-López et al, 2023, Antioxidants CrossRef
  127. null
    Gurmeet Kaur et al, 2023 CrossRef
  128. Investigation on Novel E/Z 2-Benzylideneindan-1-One-Based Photoswitches with AChE and MAO-B Dual Inhibitory Activity
    Marco Paolino et al, 2023, Molecules CrossRef
  129. D-ribose-L-cysteine exhibits restorative neurobehavioral functions through modulation of neurochemical activities and inhibition oxido-inflammatory perturbations in rats exposed to polychlorinated biphenyl
    Mega O. Oyovwi et al, 2023, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
  130. Pharmacophore-Based Screening, Molecular Docking, and Dynamic Simulation of Fungal Metabolites as Inhibitors of Multi-Targets in Neurodegenerative Disorders
    Danish Iqbal et al, 2023, Biomolecules CrossRef
  131. Design, Synthesis, and Pharmacological Evaluation of Novel Tacrine Derivatives as Multi-target ANTI-Alzheimer’s Agents In Rat Models
    Remya R.S. et al, 2023, CNSAMC CrossRef
  132. An Integrated Network Pharmacology and Molecular Modelling Study of Phytoconstituents Targeting Alzheimer's Disease
    Saumya Khanna et al, 2023, Medicine in Omics CrossRef
  133. Antioxidant, antidiabetic, neuroprotective, and phytochemical evaluation of Chenopodium ambrosioides ethanol extract
    Reem Alhasani, 2024, JMAHS CrossRef
  134. null
    Swapnil Tripathi et al, 2024 CrossRef
  135. Potential of Tryptamine Derivatives as Multi-Target Directed Ligands for Alzheimer’s Disease: AChE, MAO-B, and COX-2 as Molecular Targets
    Saira Asghar et al, 2024, Molecules CrossRef
  136. null
    Lidia de Bari et al, 2024 CrossRef
  137. null
    Bijo Mathew et al, 2024 CrossRef
  138. Dual Inhibitors of Brain Carbonic Anhydrases and Monoamine Oxidase-B Efficiently Protect against Amyloid-β-Induced Neuronal Toxicity, Oxidative Stress, and Mitochondrial Dysfunction
    Simone Giovannuzzi et al, 2024, J. Med. Chem. CrossRef
  139. Design, synthesis, in silico, and in vitro evaluation of novel benzyloxybenzene substituted (S)‐α‐amino amide derivatives as cholinesterases and monoaminoxidases inhibitor
    Akın Akıncıoğlu, 2024, Drug Development Research CrossRef
  140. Natural Products as Monoamine Oxidase Inhibitors: Potential Agents for Neurological Disorders
    Neetu Agrawal et al, 2024, CCHTS CrossRef
  141. Dual/multitargeted xanthone derivatives for Alzheimer's disease: where do we stand?
    Maria I Cruz et al, 2017, Future Medicinal Chemistry CrossRef
  142. null
    Tosin A. Olasehinde et al, 2024 CrossRef
  143. Alzheimer Disease—Link With Major Depressive Disorder and Efficacy of Antidepressants in Modifying its Trajectory
    Nour Fakih et al, 2024 CrossRef
  144. New Insights into Butyrylcholinesterase: Pharmaceutical Applications, Selective Inhibitors and Multitarget-Directed Ligands
    Tianyu Sun et al, 2024, European Journal of Medicinal Chemistry CrossRef
  145. Natural Antioxidant Anthocyanins—A Hidden Therapeutic Candidate in Metabolic Disorders with Major Focus in Neurodegeneration
    Rahat Ullah et al, 2019, Nutrients CrossRef
  146. Synthesis, characterization and biological evaluation of aurones as potential neuroprotective agents
    Muhammad Ayaz et al, 2024, Future Medicinal Chemistry CrossRef
  147. The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study
    Hai Duc Nguyen, 2024, Discov Med CrossRef
  148. In Vitro Enzyme Activity and Molecular Docking Studies of Pyrazoline Derivatives as Monoamine Oxidase Inhibitors
    Mehtap Tugrak Sakarya et al, 2024, Pharm Chem J CrossRef